Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
Language English
Content
For Research Use Only. Not for use in diagnostic procedures
Diagnosis of rare diseases presents many challenges for physicians and can lead patients on a long diagnostic odyssey. DNA sequencing panels can provide physicians answers to these challenges and resolution for patients. As a leader in rare disease diagnostics, CENTOGENE has partnered with Twist to design a series of target enrichment capture panels, providing comprehensive tools to aid in rare disease and hereditary oncology diagnosis.
The Twist Alliance CNTG Exome - 41 MB provides highly uniform coverage of the entire exome as well as full coverage of the mitochondrial genome. Combining insights from CENTOGENE’s bio/databank with exceptional omics technology, the Twist Alliance CNTG Exome - 41 MB increases diagnostic yield compared to standard whole exome sequencing and covers a broad spectrum of disorders encompassing >7,000 rare diseases.
Note: The Twist Alliance CNTG Exome - 41 MB is not ISO-13485 certified.
Total Probes 483K
Twist Human Comprehensive Exome 396.1K
Twist Mitochondrial Panel 139
Twist Alliance Centogene Rare Disease Panel 78.8 K
Centogene Spike-In 7.8 K
Twist Alliance CNTG Exome - 41 MB
105459 Twist Alliance CNTG Exome - 41 MB, 2 Reactions
105461 Twist Alliance CNTG Exome - 41 MB, 12 Reactions
105462 Twist Alliance CNTG Exome - 41 MB, 96 Reactions
© 2025 Twist Bioscience. All rights reserved.